BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5067074)

  • 1. High plasma thyrotrophin levels in two patients with pituitary tumour.
    Faglia G; Ferrari C; Neri V; Beck-Peccoz P; Ambrosi B; Valentini F
    Acta Endocrinol (Copenh); 1972 Apr; 69(4):649-58. PubMed ID: 5067074
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of the radioimmunoassay of serum thyrotrophin in man.
    Hershman JM; Pittman JA
    Ann Intern Med; 1971 Apr; 74(4):481-90. PubMed ID: 4994544
    [No Abstract]   [Full Text] [Related]  

  • 3. Case of hyperthyroidism due to a chromophobe adenoma.
    Baylis PH
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):145-50. PubMed ID: 1269160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged and exaggerated elevations in plasma thyrotropin (HTSH) after thyroptropin releasing factor (TRF) in patients with pituitary tumors.
    Faglia G; Beck Peccoz P; Ambrosi B; Ferrari C; Neri V
    J Clin Endocrinol Metab; 1971 Dec; 33(6):999-1002. PubMed ID: 5002719
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma.
    Hamilton CR; Adams LC; Maloof F
    N Engl J Med; 1970 Nov; 283(20):1077-80. PubMed ID: 5470849
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperthyroidism and excessive thyrotropin secretion.
    Emerson CH; Utiger RD
    N Engl J Med; 1972 Aug; 287(7):328-33. PubMed ID: 4114408
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of a synthetic thyrotrophin releasing hormone (TRH) in normal and endocrinopathic subjects.
    Faglia G; Beck-Peccoz P; Ambrosi B; Ferrari C; Travaglini P
    Acta Endocrinol (Copenh); 1972 Oct; 71(2):209-25. PubMed ID: 4627179
    [No Abstract]   [Full Text] [Related]  

  • 8. Is TSH-stimulated thyroid hormone release inhibited by iodide?
    Nagataki S; Uchimura H; Masuyama Y; Kosaka K
    Endocrinology; 1973 Sep; 93(3):532-9. PubMed ID: 4124492
    [No Abstract]   [Full Text] [Related]  

  • 9. Pattern of serum thyroxine, triiodothyronine and thyrotrophin after treatment of thyrotoxicosis.
    Bellabarba D; Bénard B; Langlois M
    Clin Endocrinol (Oxf); 1972 Oct; 1(4):345-53. PubMed ID: 4664297
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroid nodule autonomy: its demonstration by the thyrotrophin releasing hormone (TRH) stimulation test.
    Karlberg BE
    Acta Endocrinol (Copenh); 1973 Aug; 73(4):689-99. PubMed ID: 4126847
    [No Abstract]   [Full Text] [Related]  

  • 11. A new test of the reserve capacity of the pituitary to secrete thyrotrophic hormone (TSH-reserve test).
    Ikkos DG; Lakka-Papadidima E; Dalles K
    J Clin Endocrinol Metab; 1970 Jul; 31(1):98-101. PubMed ID: 4912879
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromophobe pituitary adenoma with acromegaly and TSH-induced hyperthyroidism associated with parathyroid adenoma. Acromegaly and parathyroid adenoma.
    Lamberg BA; Ripatti J; Gordin A; Juustila H; Sivula A; af Björkesten G
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):157-72. PubMed ID: 4308288
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioassay and the thyroid gland.
    Robbins J
    Metabolism; 1973 Aug; 22(8):1021-6. PubMed ID: 4199729
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
    Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothyroidism secondary to biologically inactive thyroid-stimulating hormone secretion by a pituitary chromophobe adenoma: recovery after removal of the tumor.
    Dickstein G; Barzilai D
    Arch Intern Med; 1982 Aug; 142(8):1544-5. PubMed ID: 7103637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay of thyrotrophin-releasing hormone (TRH) in normal subjects, in abnormal thyroid states and under catecholaminergic influences.
    Lombardi G; Panza N; Cei S; Cosimato F; Minozzi M
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):70-9. PubMed ID: 413301
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of synthetic thyrotrophin-releasing factor on pituitary TSH secretion in normal subjects and patients with hypothalamic-pituitary disorders.
    Otsuki M; Mori H; Baba S; Hiroshige N
    Acta Endocrinol (Copenh); 1973 Jun; 73(2):233-49. PubMed ID: 4199384
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperthyroidism and high serum levels of TSH associated with pituitary tumour.
    Chiarini V; Graziano E; Cremonini N; Frank G; Zampa GA
    Neurochirurgia (Stuttg); 1987 Mar; 30(2):61-3. PubMed ID: 3106846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary response to hypoglycemia in pituitary diseases.
    Genazzani AR; Ruedi B; Aubert ML; Felber JP
    Horm Metab Res; 1972 Nov; 4(6):470-7. PubMed ID: 4655503
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyrotropin releasing hormone (TRH) studies in patients with thyroid cancer.
    Samaan NA; Beceiro JR; Hill CS; Haynie TP; Glenn HJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):438-43. PubMed ID: 4626272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.